Chemical Structure (Terconazole 01)
Terconazole Suppository
Product Images NDC 51672-1330
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terconazole (NDC 51672-1330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Terconazole 02)
Figure (Terconazole 03)
Figure (Terconazole 04)
This is not enough text to generate a useful description. It appears to be two separate words, "urinary" and "opening," but without further context, it is not possible to provide any additional information or meaning.*
Figure (Terconazole 05)
Principal Display Panel (80 mg Dose Pack Carton)
This is a medication package of Terconazole Vaginal Suppositories containing 3 suppositories with a vaginal applicator. Each suppository contains 80 mg of terconazole compounded with triglycerides derived from coconut. Wrapper must not be removed unless unwrapping for use. Store at room temperature. Manufacturer information and prescription details are included in the package.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
